These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8130858)

  • 1. Bromide pharmacokinetics in cystic fibrosis.
    Miller ME; Kornhauser DM
    Arch Pediatr Adolesc Med; 1994 Mar; 148(3):266-71. PubMed ID: 8130858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
    Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin pharmacokinetics in adult cystic fibrosis.
    Lee CKK; Boyle MP; Diener-West M; Brass-Ernst L; Noschese M; Zeitlin PL
    Chest; 2007 Mar; 131(3):796-802. PubMed ID: 17356095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloxacillin absorption and disposition in cystic fibrosis.
    Spino M; Chai RP; Isles AF; Thiessen JJ; Tesoro A; Gold R; MacLeod SM
    J Pediatr; 1984 Nov; 105(5):829-35. PubMed ID: 6502318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cephalexin pharmacokinetics in patients with cystic fibrosis.
    Nahata MC; Lubin AH; Visconti JA
    Dev Pharmacol Ther; 1984; 7(4):221-8. PubMed ID: 6468223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.
    Kearns GL; Hilman BC; Wilson JT
    J Pediatr; 1982 Feb; 100(2):312-8. PubMed ID: 7035640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and clinical utility of sodium bromide (NaBr) as an estimator of extracellular fluid volume in horses.
    Fielding CL; Magdesian KG; Elliott DA; Craigmill AL; Wilson WD; Carlson GP
    J Vet Intern Med; 2003; 17(2):213-7. PubMed ID: 12683623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweat bromide excretion in cystic fibrosis.
    Miller ME; Cosgriff JM; Schwartz RH
    J Lab Clin Med; 1986 Nov; 108(5):406-10. PubMed ID: 3772221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probenecid pharmacokinetics in cystic fibrosis.
    Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
    Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal clearance of gentamicin in cystic fibrosis.
    MacDonald NE; Anas NG; Peterson RG; Schwartz RH; Brooks JG; Powell KR
    J Pediatr; 1983 Dec; 103(6):985-90. PubMed ID: 6644440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.
    Levy J; Smith AL; Koup JR; Williams-Warren J; Ramsey B
    J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis.
    Moriconi N; Kraenzlin M; Müller B; Keller U; Nusbaumer CP; Stöhr S; Tamm M; Puder JJ
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1586-90. PubMed ID: 16464949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Nerup J; Koch C
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):217-23. PubMed ID: 7923827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval.
    Horrevorts AM; Degener JE; Dzoljic-Danilovic G; Michel MF; Kerrebijn KF; Driessen O; Hermans J
    Chest; 1985 Aug; 88(2):260-4. PubMed ID: 4017681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime disposition in acute and stable cystic fibrosis.
    Leeder JS; Spino M; Isles AF; Tesoro AM; Gold R; MacLeod SM
    Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of antibiotics in cystic fibrosis.
    Akkerman-Nijland AM; Akkerman OW; Grasmeijer F; Hagedoorn P; Frijlink HW; Rottier BL; Koppelman GH; Touw DJ
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):53-68. PubMed ID: 33213220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast pharmacokinetics in cystic fibrosis.
    Graff GR; Weber A; Wessler-Starman D; Smith AL
    J Pediatr; 2003 Jan; 142(1):53-6. PubMed ID: 12520255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation.
    Walsh KA; Davis GA; Hayes D; Kuhn RJ; Weant KA; Flynn JD
    Transpl Infect Dis; 2011 Dec; 13(6):616-21. PubMed ID: 21794042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of bromide in adult sheep following oral and intravenous administration.
    Quast TA; Combs MD; Edwards SH
    Aust Vet J; 2015; 93(1-2):20-5. PubMed ID: 25622704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis.
    Wang XX; Feng MR; Nguyen H; Smith DE; Cibrik DM; Park JM
    Eur J Clin Pharmacol; 2015 Jun; 71(6):673-679. PubMed ID: 25943384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.